Niki BioSolutions, Inc. Deferred Tax Assets, Gross
Niki BioSolutions, Inc. (NIKI) had Deferred Tax Assets, Gross of $15.99 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-05-11
- 2025-12-31: Deferred Tax Assets, Gross $15.99M.
- 2024-12-31: Deferred Tax Assets, Gross $15.77M.
- 2023-12-31: Deferred Tax Assets, Gross $17.41M.
- 2022-12-31: Deferred Tax Assets, Gross $15.81M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $15.99M S-4/A · filed 2026-05-11 |
| 2024-12-31 | $15.77M S-4/A · filed 2026-05-11 |
| 2023-12-31 | $17.41M 6-K · filed 2025-10-08 |
| 2022-12-31 | $15.81M 20-F · filed 2024-04-30 |
| 2021-12-31 | $12.89M 20-F · filed 2023-04-28 |
| 2020-12-31 | $9.96M 20-F/A · filed 2023-01-17 |
| 2019-12-31 | $6.70M 20-F · filed 2021-04-19 |